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We analysed the results of oocyte donation to women of
advanced reproductive age (^45 years old) and followed
their pregnancies through to delivery in order to assess
obstetrical outcomes. Patients (n = 162) aged 45-59 years
(mean ± SD; 47.3 ± 3.4 years) underwent 218 consecutive
attempts to achieve pregnancy. Oocytes (16.2 ± 7.2 per
retrieval) were provided by donors £35 years old. Cleaving
embryos (8.2 ± 4.8 zygotes/couple) were transferred trans-
cervically (4.5 ± 1.1 per embryo transfer) to recipients
prescribed oral micronized oestradiol and intramuscular
progesterone. Following oocyte aspiration there were six
instances of non-fertilization (2.8%) and 212 embryo trans-
fers. A total of 103 pregnancies was established for an
overall pregnancy rate (PR) of 48.6%, which included 17
preclinical pregnancies, 12 spontaneous abortions, and 74
delivered pregnancies (clinical PR 40.6%; delivered PR
34.9%). Multiple gestations were frequent (n = 29; 39.2%
of pregnancies) and included 20 twins, seven triplets, and
two quadruplets. Two of the triplet and both of the
quadruplet pregnancies underwent selective reduction to
twins. Antenatal complications occurred in 28 women
(37.8% of deliveries) and included preterm labour (n = 9),
gestational hypertension (n = 8), gestational diabetes
(n = 6), carpel tunnel syndrome (n = 2), pre-eclampsia
(n = 2), HELLP syndrome (n = 2), and fetal growth
retardation (n = 2). 48 (64.8%) deliveries were by Caesa-
rean section. The gestational age at delivery for singletons
was 3 8 3 ± 1.3 weeks (range 35-41 weeks), with birth
weight 3218 ± 513 g (range 1870-4775 g); twins 35.9 ± 2.0
weeks (range 32-39 weeks), birth weight 2558 ± 497 g
(range 1700-3450 g); and triplets 33.5 ± 0.7 weeks (range
32-34 weeks), birth weight 1775 ± 190 g (range 1550-
2100 g). Neonatal complications (4.6% of babies born)
included growth retardation (n = 2), trisomy 21 (n = 1),
ventricular septal defect (n = 1), and small bowel obstruc-
tion (n = 1). There were no maternal or neonatal deaths.
We conclude that oocyte donation to women of advanced
reproductive age is highly successful in establishing preg-
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nancy. However, despite careful antenatal screening, obstet-
rical complications are common, often secondary to
multiple gestation.
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Introduction
For over 10 years oocyte and embryo donation has been used
to establish pregnancies in women with infertility (Sauer,
1995a). Although applied principally to young women with
hypergonadotrophic hypogonadism (Hens et al, 1989;
Rotsztejn et al, 1990), this method has recently been utilized
to treat age-related infertility (Flamigni et al., 1993; Sauer
et al., 1994; Lydic et al, 1996). Success rates following oocyte
donation to women in their forties and fifties have generally
been similar to rates seen in younger women (Serhal and Craft,
1989; Sauer et al, 1992; Sauer, 1994).
Most studies of older recipients are preliminary in nature,
and lack meaningful obstetrical follow-up. However, anecdotal
case reports imply that outcomes are favourable (Blanchette,
1993). Concerns do exist with respect to extending therapy to
older women and are based principally upon beliefs that
pregnancy presents a high medical risk /o r both mother
and fetus (Editorial: Lancet, 1993). This report details our
expenence in caring for women nearing or beyond the natural
menopause using oocyte donation. Included are both the
reproductive and the obstetrical outcomes of this clinical trial.
Materials and methods
The protocol for oocyte and embryo donation was approved by the
Institutional Review Board of the California Medical Center, Los
Angeles. Women in good physical and psychological health were
considered as potential recipients. Prospective patients underwent
medical, reproductive and psychological screening examinations prior
to enrolment in the programme. Table I lists the prescreening
examinations required of subjects.
In 1990 the protocol was amended to include women up to the
age of 59 years. Between January 1990 and July 1994, 199 patients
over the age of 45 years were screened Of these, 37 were not
permitted entry into the programme due to the following detected
abnormalities, gross distortion of the endometrial cavity by leiomy-
omata (n = 13); abnormal exercise treadmill electrocardiograms (n =
11); diabetes meUitus with abnormal glucose tolerance and fasting
hyperinsulinaemia (n = 7); occult carcinomas (n = 4); perceived
psychological instability (n = 1); and multiple sclerosis (n = 1).
A total of 162 women successfully met the screening criteria and
were enrolled into the clinical trial. Of these patients, 99 (61.1%)
had not previously delivered a child. The mean age of their husbands
was 47.3 ± 3.4 years (mean ± SD). In the majority of couples, one
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Table L Medical and reproductive screening required of recipients >45






Fasting cholesterol and blood lipoproteins
Blood chemistry panel (SMA 12/60)
Thyrotrophin (sensitive thyroid-stimulating hormone)
Antinuclear antibody, lupus anticoagulant, anucardiohpin antibody




Endometrial biopsy (day 21)
Hysterosalpingogram
Infectious disease
Human immunodeficiency virus (HTV)
Venereal Disease Research Laboratory (VDRL)
Hepatitis
or both members were married for a second time (n = 119; 73.5%).
The mean duration of the present marriage was 9.1 ± 3 1 years
(range 2-34).
Prospective recipients were placed on a regimen of hormone
replacement consisting of oral nucronized oestradiol and intramuscu-
larly administered progesterone, as previously described (Sauer et al,
1989). In women still experiencing regular menstrual periods pituitary
down-regulation with gonadotrophin releasing hormone agonist
(GnRHa) was used to render them functionally agonadal pnor to the
initiation of sex steroids. Recipients completed a 'mock cycle' while
using these hormones to assess the response of die endometnum.
Endometrial biopsies were obtained on day 21 of the artificial cycle,
and in all cases were found to be secretory in nature
Donors provided gametes after pituitary downregulation with
GnRHa followed by ovanan hyperstimulation with human menopausal
gonadotrophin. Most commonly gametes were donated anonymously
(n = 177; 83 5%). hi 41 instances oocytes were provided to couples
by known designated donors, friends (n = 12); daughters from a
previous marriage (n = 6); sisters (n = 2); or the USC programme
(n = 21). Donors were screened according to the American Fertility
Society Guidelines (American Fertility Society, 1993) which included
a history and physical examination, pap smear, and testing for
hepatitis, human immunodeficiency virus (HIV), and syphilis. The
mean age of donors was 30.3 ± 4.3 years, with a range of 21-35 years.
Males were screened using semen analyses, and semen bacterial
cultures. In men who had not previously fathered children a hamster
egg penetration assay was also performed If abnormalities were
discovered in any of these tests, spermatozoa were incubated in test-
yolk buffer before in-vitro insemination in an effort to improve the
fertilization rate (Paulson et al, 1992).
Couples were interviewed by psychologists pnor to entry into the
study. Interviews were open-ended discussions without use of formal
psychological tests. Emphasis was placed on issues of parenting and
child support especially with respect to advanced age and longevity.
All couples were counselled about the known and potential increased
obstetric risks associated with pregnancy at an advanced reproductive
age (Hollander and Breen, 1990). The possible increased genetic risks
associated with conception using spermatozoa of men aged >55
years were also discussed (Stene et aL, 1977).
Preclimcal pregnancies were defined as women with demonstrable
Utres (>1.5 mIU/ml; International Reference Preparation) of beta-
human chorionic gonadotrophin (p-HCG) in the serum 9 and 12 days
Table IL Results of in-vitro femhzauon and embryo transfer to 162 women
No aspirations
No cycles without fertilization
No embryo transfers (ET)
No pregnancies established (% of ET)
precbnical pregnancies
clinical abortions
delivered (% of ET)












m . Obstetrical outcomes of 74 deliveries
Mean ± SD Range
Singletons (n = 45)
Birth weight (g)







Twins (n = 24)
Birth weight (g) 2558 ± 497 1700-3450
Gestational age at delivery (weeks) 35 9 ± 2 0 weeks 32-39
Triplets (n = 5)
Birth weights (g) 1775 ± 190 1550-2100
Gestational age at delivery (weeks) 33 5 ± 0 7 weeks 32-34
Operative deliveries 48 of 74 (64 8%)
following embryo transfer, yet failing to progress to an ultrasonograph-
lcally detectable gestational sac Clinical pregnancies were defined
as pregnancies with gestational sacs noted on transvaginal ultrasound.
Continuing pregnancies progressed beyond the second trimester and
were followed until delivery. Obstetncal and neonatal outcomes were
gained first-hand from the physician in attendance or by interviewing
patients post partum. Information on patients was available through
to the time of their discharge from the hospital.
Results
Between January 1990 and July 1995,218 consecutive attempts
at oocyte donation were initiated on behalf of 162 couples.
Oocytes (16.2 ± 7.2 per retrieval) were obtained during each
aspiration. Following fertilization, cleaving embryos (8.2 ±
4.8 zygotes per couple per retrieval) were cultured in vitro. At
48-72 h later, embryos were transferred transcervically (4.5
±1 .1 embryos per embryo transfer). In six instances fertiliza-
tion did not occur, thus resulting in 212 embryo transfers.
Table II lists the results of in-vitro fertilization and embryo
transfer following oocyte donation with respect to the establish-
ment of pregnancy in these women.
Multiple gestations occurred in 29 of 74 delivered pregnan-
cies (39.2%). This included 20 twin, seven triplet, and two
quadruplet gestations Two of the triplet and both of the
quadruplet pregnancies underwent selective reduction to twins
in the early second trimester. Table HI describes the obstetrical
outcomes. The age of mothers delivering infants was not
statistically significantly different from that of women who
failed to conceive (47.3 ± 3.3 years compared with 48 1 ±
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Ibble IV. Complications




Premature rupture of membranes
Placenta praevia






















"Haemolysis, Elevated Liver enzymes. Low Platelets, as defined by Shaw
(1994)
in 28 women (37.8%). Table IV lists the obstetrical and
neonatal problems encountered. There were no maternal or
neonatal deaths.
Discussion
Perhaps the most controversial application of oocyte donation
has been its use in circumventing age-related infertility in
patients nearing or beyond menopause. This practice has
become increasingly common, and today a significant percent-
age of older women in the United States undergo oocyte
donation. The trend towards older parenting is consistent with
several changes evident in the general population (Baldwin
and Windquist Nord, 1984). The number of women between
the ages of 35 and 50 is steadily increasing. Also, more women
are employed outside the home, and many are electing to
delay childbirth for personal, economic or professional reasons.
In the last decade, the number of pnmigravid pregnancies over
the age of 30 has doubled and has increased by 80% for
mothers nearing 40 years. It is projected that by the year 2000
approximately 10% of all births will occur in women over the
age of 35 (Hansen, 1986).
Fertility potential decreases with advancing maternal age,
and it is expected that most older women will be unsuccessful
in their efforts to reproduce. Extending of oocyte donation to
this group of patients allows a critical assessment of factors
accounting for the reduced fertility associated with advancing
age. Numerous reports document that advanced maternal age
does not diminish pregnancy rates in women undergoing
oocyte donation (Navot et al, 1991, 1994; Lydic et al., 1996).
In fact, as noted by our present study, the implantation and
pregnancy rates are the same in perimenopausal women as
those rates experienced by younger women undergoing oocyte
donation (Sauer et al, 1994). With proper hormone preparation
the endometrium retains its receptivity to embryo implantation,
suggesting that the decreasing fecundity normally seen in older
women is primarily due to ovarian rather than uterine factors
(Antinori et al, 1993; Borini, 1995; Sauer, 1995b).
Medical and obstetrical complications occur with increased
frequency in pregnant women of advanced reproductive age,
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whether the conception is spontaneous or assisted (Cnattingius
et al, 1992). It is often difficult to determine if the observed
increase is due to age alone or to other confounding variables
such as pre-existing disease, obesity, parity and socioeconomic
factors. Glucose intolerance clearly increases with age and
may present as pregestational or gestational diabetes. This
risk is further influenced by obesity. In a review comparing
pregnancy in women over the age of 40 years with women
under 30, Spellacy described a 4-fold increase in diabetes,
complicating up to 1% of the pregnancies in the older age
group (Spellacy et al, 1986). Similarly, hypertension also
occurs with increased frequency, and advanced maternal age
is associated with an increased incidence of pregnancy-induced
hypertension (PM). Various studies have cited up to a 5-fold
increase in hypertensive complications in the older gravida
(Cunningham et al, 1989; Newcomb et al., 1991). However,
a significant proportion of this risk is based upon the presence
of pre-existing disease or obesity. In previous reports of older
women pregnant following oocyte donation, PIH has been
noted in 20-30% of mothers (Serhal and Craft, 1989; Sauer
et al., 1995; Shaw and Sauer, 1995).
Advanced maternal age has been reported to impact upon
perinatal morbidity and mortality. Complications include low
birth weight, intrauterine fetal demise, and neonatal mortality
(Naeye, 1983; Flamigni et al, 1993; Flamigni and Borini,
1995). Other studies dismiss the association of age and
complications when controlling for pre-existing diseases and
prenatal care (Adashek et al, 1993). Information from oocyte
recipients has not indicated an increase in neonatal morbidity
or mortality. This may be attributable to the excellent health
of women prescreened to receive donor oocytes, and the high
risk obstetrical care with which they are provided.
Recipients of donor oocytes experience a high rate of
operative delivery. Many patients undergo elective induction
of labour which is not always successful. The high frequency of
multifetal pregnancies further contributes to the high Caesarean
rate. While up to 50% of twin gestations can undergo a vaginal
delivery, most physicians are reluctant to deliver women over
the age of 45 in this manner. This is especially true for
primigravid patients who become pregnant following oocyte
donation.
Multifetal pregnancies occur in approximately one-third
of recipients and carry potentially significant complications,
especially if involving higher order gestations (triplets and
above). This high incidence of multiple gestations is clearly
related to the number of embryos transferred. The number of
embryos transferred differs in various studies, but usually
ranges from three to six per transfer. In order to make fair and
accurate comparisons in implantation rates between older and
younger recipients we elected to transfer up to five pre-embryos
per patient. We were not expecting that high implantation rates
would be maintained in this group of older patients, based
upon animal models that show a decline in both implantation
and pregnancy rates with ageing (Holinka et al, 1979).
Therefore, we were also not anticipating problems with multiple
gestations in older recipients. The vast majority of multifetal
gestations result from multiple implantations rather than mono-
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gestations have improved dramatically in recent years, these
pregnancies remain at risk for first trimester bleeding, anaemia,
preterm birth, low birth weight, intrauterine growth retardation,
fetal demise and PIH.
In conclusion, the introduction of oocyte donation to estab-
lish pregnancy in patients with age-related infertility has
allowed many older women a new opportunity to conceive. The
reproductive years now extend beyond menopause. Properly
screened couples can anticipate a high degree of success in
achieving pregnancy. The increased frequency of multifetal
gestations deserves attention in the hope of avoiding the higher
order multifetal pregnancies that require selective reduction.
Consideration should be given to reducing the number of pre-
embryos transferred to a maximum of three in order to decrease
this risk to a reasonable level. An increased risk for antenatal
complications exists, and needs to be carefully assessed during
the initial stages of consultation in order to screen out indi-
viduals known to have pre-existing diseases that would further
complicate a high risk pregnancy. However, when selection is
properly carried out, the majority of oocyte donation recipients
will experience a good outcome to their pregnancy
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